Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-28 @ 11:48 AM
Study NCT ID:
NCT06140966
Status:
RECRUITING
Last Update Posted:
2025-04-16
First Post:
2023-11-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-20
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-20
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-14
First Submit QC Date:
None
Study First Post Date:
2023-11-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-12
Last Update Post Date:
2025-04-16
Last Update Post Date Type:
ACTUAL